159 related articles for article (PubMed ID: 25529464)
1. Gastric mucosa-associated lymphoid tissue lymphoma in a patient with severe psoriasis receiving ustekinumab.
González-Ramos J; Alonso-Pacheco ML; Mayor-Ibarguren A; Herranz-Pinto P
Actas Dermosifiliogr; 2015 May; 106(4):326-7. PubMed ID: 25529464
[No Abstract] [Full Text] [Related]
2. Morphea in a Patient With Psoriasis on Treatment With Ustekinumab: Comorbidity or Adverse Effect?
Corral Magaña O; Escalas Taberner J; Escudero Góngora MM; Giacaman Contreras A
Actas Dermosifiliogr; 2017 Jun; 108(5):487-489. PubMed ID: 28110825
[No Abstract] [Full Text] [Related]
3. Fatal thrombotic thrombocytopenic purpura in a psoriasis patient treated with ustekinumab and methotrexate.
Philippe L; Badie J; Faller JP; Krattinger É; Deconinck E; Aubin F
Acta Derm Venereol; 2015 Apr; 95(4):495-6. PubMed ID: 25325260
[No Abstract] [Full Text] [Related]
4. Severe dilated cardiomyopathy induced by adalimumab and ustekinumab.
Membrillo de Novales FJ; Ávila Jiménez A; Merino Meléndez L; Torres León J; López Soberón E; Fe Marqués A; Pérez Mochales JF
J Clin Rheumatol; 2015 Apr; 21(3):171-3. PubMed ID: 25807103
[No Abstract] [Full Text] [Related]
5. Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab.
Čarija A; Ivić I; Marasović-Krstulović D; Puizina-Ivić N
Rheumatology (Oxford); 2015 Nov; 54(11):2114-6. PubMed ID: 26242857
[No Abstract] [Full Text] [Related]
6. Arthritis possibly induced and exacerbated by a tumour necrosis factor antagonist in a patient with psoriasis vulgaris.
Takahashi T; Asano Y; Shibata S; Nakamura K; Nakao M; Shida R; Mitsui A; Araki M; Watanabe R; Fujita H; Tada Y; Sato S
Br J Dermatol; 2015; 172(5):1458-60. PubMed ID: 25565011
[No Abstract] [Full Text] [Related]
7. [Methotrexate: safe if prescribed correctly].
Verduijn MM; van den Bemt BJ; Dijkmans BA; van der Waal RI; Horikx A
Ned Tijdschr Geneeskd; 2009; 153():A695. PubMed ID: 19785857
[TBL] [Abstract][Full Text] [Related]
8. Safety of ustekinumab in severe psoriasis with chronic hepatitis B.
Raymundo AR; Facin AP; Silva de Castro CC; Faria AR
Indian J Dermatol Venereol Leprol; 2016; 82(3):326-8. PubMed ID: 27088944
[No Abstract] [Full Text] [Related]
9. Treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis: a report of 2 cases.
Chu DH; Van Voorhees AS; Rosenbach M
Arch Dermatol; 2011 Oct; 147(10):1228-30. PubMed ID: 22006150
[No Abstract] [Full Text] [Related]
10. Ustekinumab treatment in patients with psoriasis undergoing hemodialysis.
Umezawa Y; Hayashi M; Kikuchi S; Fukuchi O; Yanaba K; Ito T; Asahina A; Saeki H; Nakagawa H
J Dermatol; 2015 Jul; 42(7):731-4. PubMed ID: 25959602
[TBL] [Abstract][Full Text] [Related]
11. The Use of Methotrexate, Alone or in Combination With Other Therapies, for the Treatment of Palmoplantar Psoriasis.
Wald JM; Klufas DM; Strober BE
J Drugs Dermatol; 2015 Aug; 14(8):888-92. PubMed ID: 26267735
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate and other chemotherapeutic agents used to treat psoriasis.
Jeffes EW; Weinstein GD
Dermatol Clin; 1995 Oct; 13(4):875-90. PubMed ID: 8785891
[TBL] [Abstract][Full Text] [Related]
13. Complete remission of chronic plaque psoriasis and gastric marginal zone B-cell lymphoma of MALT type after treatment with 2-chlorodeoxyadenosine.
Valencak J; Trautinger F; Fiebiger WC; Raderer M
Ann Hematol; 2002 Nov; 81(11):662-5. PubMed ID: 12454707
[TBL] [Abstract][Full Text] [Related]
14. From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies.
Hugh J; Van Voorhees AS; Nijhawan RI; Bagel J; Lebwohl M; Blauvelt A; Hsu S; Weinberg JM
J Am Acad Dermatol; 2014 Jan; 70(1):168-77. PubMed ID: 24184141
[TBL] [Abstract][Full Text] [Related]
15. Safety of ustekinumab for the treatment of psoriasis vulgaris with myotonic dystrophy.
Fujita Y; Shinkuma S; Nomura T; Shimizu H
Eur J Dermatol; 2016 Apr; 26(2):187-8. PubMed ID: 26643260
[No Abstract] [Full Text] [Related]
16. Atopic dermatitis exacerbated with ustekinumab in a psoriatic patient with childhood history of atopy.
Lis-Święty A; Skrzypek-Salamon A; Arasiewicz H; Brzezińska-Wcisło L
Allergol Int; 2015 Oct; 64(4):382-3. PubMed ID: 26433537
[No Abstract] [Full Text] [Related]
17. Combination use of ustekinumab with other systemic therapies: a retrospective study in a tertiary referral center.
Heinecke GM; Luber AJ; Levitt JO; Lebwohl MG
J Drugs Dermatol; 2013 Oct; 12(10):1098-102. PubMed ID: 24085044
[TBL] [Abstract][Full Text] [Related]
18. Adverse reactions during biological drug therapy in psoriasis:clinical series and a review of the literature.
Montesu MA; Addis GM; Satta R; Cottoni F
G Ital Dermatol Venereol; 2011 Aug; 146(4):273-81. PubMed ID: 21785393
[TBL] [Abstract][Full Text] [Related]
19. Intracranial hypertension syndrome in a patient with psoriasis receiving ustekinumab.
Reyes Bueno JA; Reyes Garrido V; León A; Bustamante R
Neurologia (Engl Ed); 2019 May; 34(4):281-282. PubMed ID: 28712842
[No Abstract] [Full Text] [Related]
20. Ustekinumab: new drug. Suspicion of carcinogenicity: too great a risk for psoriasis patients.
Prescrire Int; 2009 Oct; 18(103):202-4. PubMed ID: 19882785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
